相关实验视频
Updated: Aug 1, 2026

13:51
The MultiBac Protein Complex Production Platform at the EMBL
Published on: July 11, 2013
通过红红多基基合成酶对16个成员的宏化物进行前体导向生物合成
K Kinoshita1, P G Williard, C Khosla
1Department of Chemistry, Box H, Brown University, Providence, Rhode Island 02912-9108, USA.
Journal of the American Chemical Society
|July 18, 2001
概括
在Streptomyces coelicolor中突变的6-deoxyerythronolide B合成酶接受了三胺类同类物,形成了一种八胺类麦克罗拉克. 这揭示了对聚基酸合成酶基底特异性和新型巨乳素生物合成的洞察力.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 合成生物学 合成生物学
背景情况:
- 斯特雷普托米塞斯 coelicolor CH999/pJRJ2 含有一种突变的6-deoxyerythronolide B 合成酶 (DEBS),具有受阻的合成酶 (KS1) 活性部位.
- 这种突变阻止了6-deoxyerythronolide B的自然生物合成,这是一个关键的多基化物.
研究的目的:
- 为了研究突变DEBS酶的基质特异性.
- 探索使用工程聚基酸合成酶的新型麦克罗拉克生物合成的潜力.
主要方法:
- 将合成三胺类同类剂给表达突变DEBS.的S. coelicolor培养物.
- 通过分析技术,分离并对得到的麦克罗拉克产品进行表征.
主要成果:
- 用一种特定的不和三基胺类同类物 (6) 进行化,产生了一种新型的16个分子八基胺麦克罗拉克 (33).
- 这表明突变DEBS处理了三化物作为二化物模拟物,引入模块2.
- 其他类似物 (18,31,32) 也产生了相应的麦克罗拉克顿 (34,35,36),证实了基质的接受.
- 一种C-2脱甲基化模拟物 (10) 无法产生巨乳素,这凸显了特定结构特征的重要性.
结论:
- 突变的DEBS酶表现出改变的基质特异性,可以接受三胺类似物.
- 这种工程系统允许新型巨乳素的新合成.
- 这项研究提供了有关多基酸链延长机制和生物合成酶工程的宝贵见解.
相关概念视频
Initiation of Translation
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Directing Proteins to the Rough Endoplasmic Reticulum
The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
Biosynthesis in Bacteria
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
Biosynthesis of Lipids
Microbial membranes exhibit remarkable diversity in lipid composition, reflecting evolutionary adaptations to various environmental conditions. The three domains of life—Bacteria, Archaea, and Eukarya—synthesize membrane lipids through distinct biosynthetic pathways, leading to fundamental structural differences that impact membrane stability, function, and adaptability.Fatty Acid-Based Lipids in Bacteria and EukaryaBacteria and eukaryotes share a common fatty acid biosynthesis pathway, which...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...

